Latest App Notes & Case Studies

This application note presents a comprehensive study comparing an ATMP release kit with an alternative PCR-based solution, evaluating both sensitivity and workflow convenience for ATMP quality control laboratories.

This application note demonstrates a novel workflow for comprehensive ADC evaluation in 3D tumor spheroid models, offering deeper insights into drug function and cellular response.

This application note provides data-driven insights for optimizing cfDNA workflows, from initial sample input to final sequencing parameters.

This application note demonstrates how combining live-cell analysis with high-throughput screening cytometry enables continuous, non-invasive monitoring of MSC differentiation, offering unprecedented insights into cellular dynamics while preserving

Flow cytometers struggle with complex samples, slow rates, and panel limits. Next-gen technology enables fast, multidimensional analysis with acoustic-assisted hydrodynamic focusing and expanded spectral capabilities and data loss.

This application note explores a novel single-use static inline mixer for controlled alkaline lysis of E. coli cells. Designed for scalability, it ensures high yields and product integrity in volumes up to 200 L, streamlining the midstream pDNA proce

This application note highlights how combining relative oxygen consumption rate (rOCR) assays with imaging technologies can transform mitochondrial research, featuring workflows and examples that simplify complex analyses.

This application note examines how advanced tube designs and sealing technologies address these risks and help maintain sample quality across a range of working volumes over 3 years.

This application note showcases how an AI-based module has been trained to analyze brightfield images for cell segmentation, allowing insights into cell proliferation and cell morphology without the need for manual drawing on images.

This case study highlights a novel platform that enabled a research team to identify, isolate and expand rare NIH-3T3 clones expressing HER2 and EBFP2, achieving results in weeks rather than months.